Retracted : Antiproliferative Efficacy of Hesperetin (Citrus Flavanoid) in 1,2-Dimethylhydrazine-Induced Colon Cancer (Phytotherapy Research, (2013), 27, 7, (999-1005), 10.1002/ptr.4826);Antiproliferative efficacy of hesperetin (Citrus Flavanoid) in 1,2-dimethylhydrazine-induced colon cancer

Phytotherapy Research

Volumn 27, Issue 7, 2013, Pages 999-1005

  Aranganathan, Selvaraj ^a   Nalini, Namasivayam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

aberrant crypt foci; AgNORs; antiproliferation; colon cancer; hesperetin; PCNA

Indexed keywords

CYCLINE; HESPERETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BODY WEIGHT; CANCER CELL; CANCER GROWTH; CANCER INCIDENCE; CELL COUNT; CELL NUCLEUS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; MALE; NONHUMAN; RAT; TREATMENT RESPONSE; TUMOR VOLUME;

CITRUS; RATTUS;

EID: 84879976165     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.6911     Document Type: Erratum

References (35)

1. Aranganathan S, Panneer Selvam J, Nalini N,. 2008. Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: a dose-dependent study. J Pharm Pharmocol 60: 1385-1392.
2. Bird RP,. 1995. Role of ACF in understanding the pathogenesis of colon cancer. Cancer Lett 93: 55-71.
3. Bok SH, Lee SH, Park YB, et al,. 1999. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 129: 1182-1185.
4. Cai YZ, Luo Q, Sun M, Corke H,. 2004. Antioxidant activity and phenolic compounds of 112 traditional. Life Sci 74: 2157-2184.
5. Carr NJ, Monihan JM, Nzeako UC, Murakata LA, Sobin LH,. 1995. Expression of proliferating cell nuclear antigen in hyperplastic polyps, adenomas and inflammatory cloacogenic polyps of the large intestine. J Clin Pathol 48: 46-52.
6. Chang WL, Chapkin RS, Lupton JR,. 1997. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumourigenesis, Carcinogenesis 18: 721-730.
7. Chapkin RS, Lupton JR,. 1999. Colonic cell proliferation and apoptosis in rodent species. Modulation by diet. Adv Exp Med Biol 470: 105-118.
8. Choi EJ,. 2007. Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21. Nutr Cancer 59: 115-119.
9. Choi EJ, Kim GD, Chee KM, Kim GH,. 2006. The effects of hesperetin on vessel structure formation in moue embryonic stem (mES) cell. Nutrition 22: 947-951.
10. Cohen SM,. 1998. Cell proliferation and carcinogenesis. Drug Metab Rev 30: 339-357.
11. Garg A, Garg S, Zaneveld LJ, Singla AK,. 2001. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 15: 655-669.
12. Guthrie N, Carroll KK,. 1998. Inhibition of mammary cancer by citrus flavonoids. Adv Exp Med Biol 439: 227-236.
13. Hall PA, Levinson DA, Woods AL, et al,. 1990. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasm. J Pathol 162: 285-294.
14. Hirose Y, Kuno T, Yamada Y, et al,. 2003. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis 24: 107-111.
15. Jackson PE, O'Connor PJ, Cooper DP, Margison GP, Povey AC,. 2003. Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis 24: 527-533.
16. Jemal A, Murray T, Ward E, et al,. 2005. Cancer statistics. CA Cancer J Clin 55: 10-30.
17. Johnson GC, Margaret A, Miller, Ramos-Vara JA,. 1995. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumours and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa. J Vet Diagn Invest 7: 127-136.
18. Kanna PS, Mahendrakumar CB, Chakraborty T, Hemalatha, Banerjee P, Chatterjee M,. 2003. Effect of vanadium on colonic aberrant crypt foci induced in rats by 1,2-dimethylhydrazine. World J Gastroenterol 9: 1020-1027.
19. Kohno H, Suzuki R, Noguchi R, Hosokawa M, Miyashita K, Tanaka T,. 2002. Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Jpn J Cancer Res 93: 133-142.
20. Lin N, Sato T, Takayama, et al,. 2003. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol 65: 2065-2071.
21. Masachika S, Xue-Yun Z, Hideyo I,. 2000. Proliferating cell nuclear antigen (PCNA), nucleolar organizer regions (AgNORs), and mitotic indeces in nasopharyngeal carcinoma. Acta Med Nagasaki 38: 200-205.
22. Mori H, Yoshimi N, Tanaka T, Hirose Y,. 1996. Experimental colorectal carcinogenesis; role of cell proliferation. In Recent Advances in Gastroenterological Carcinogenesis I, Tahara E, Sugimachi K, Oohara T, (eds). Monduzzi Editore: Bologna, 249-254.
23. Mouly P, Gaydou EM, Auffray A,. 1998. Simultaneous separation of flavanone glycosides and polymethoxylated flavones in citrus juices using lipid chromatography. J Chromatogr A 800: 171-179.
24. Murray PG, Boldy DA, Crocker J, Ayres JG,. 1989. Sequential demonstration of antigens and AgNORs in frozen and paraffin sections. J Pathol 159: 553-557.
25. Pignatelli M, Stamp GWH, Kafiri G, Lane D, Bodmer WF,. 1992. Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Intl Cancer 50: 683-638.
26. Ponz de Leon M,. 1996. Genetic basis of tumour development. Ital J Gastroenterol 28: 232-245.
27. Schulmann K, Reiser M, Schmiegel W,. 2002. Colonic cancer and polyps. Best Pract Res Clin Gastroenterol 16: 91-114.
28. Shin YW, Bok SH, Jeong TS, et al,. 1999. Hypocholesterolemic effect of naringin associated with hepatic cholesterol regulating enzyme changes in rats. Int J Vitam Nutr Res 69: 341-347.
29. Singh RP, Banerjee S, Kumar PVS, Raversha KA, Rao AR,. 2006a. Tinospora cardifolia induces enzymes of carcinogen/drug metabolism and antioxidant system, and inhibit lipid peroxidation in mice. Phytomedicine 13: 74-84.
30. Singh U, Singh R, Srivastava AN, et al,. 2006b. AgNOR count and its diagnostic significance in cervical intraepithelial neoplasia. J Obstet Gynecol India 56: 244-246.
31. Slattery ML, Benson J, Curtin K, Ma KN, Schaeffer D, Potter JD,. 2000. Carotenoids and colon cancer. Am J Clin Nutr 71: 575-582.
32. Tanaka T, Kojima M, Suzui M, Mori H,. 1993. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumour development and biomarkers expression of colon tumourigenesis. Cancer Res 53: 3908-3913.
33. Winawer S, Fletcher R, Rex D, et al,. 2003. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124: 544-560.
34. Yamada K, Yoshitke K, Sato M, Ahnen DJ,. 1992. Proliferating cell nuclear antigen expression in normal, preneoplastic colonic epithelium of the rat. Gastroenterology 103: 160-167.
35. Zhang XQ,. 1996. Progress of study on suppresser, EGFR and PCNA in colorectal cancer. Xin Xiaohuabingxue Zazhi 4: 327-328.